Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.9K Sell
115
-20
-15% -$5.65K ﹤0.01% 807
2026
Q1
$36.5K Sell
135
-4
-3% -$1.11K ﹤0.01% 668
2025
Q4
$39.5K Sell
139
-102
-42% -$28.6K ﹤0.01% 488
2025
Q3
$75K Buy
241
+135
+127% +$39.9K 0.01% 288
2025
Q2
$34K Sell
106
-1
-0.9% -$322 ﹤0.01% 311
2025
Q1
$35.2K Hold
107
﹤0.01% 288
2024
Q4
$29.5K Sell
107
-28
-21% -$8.93K ﹤0.01% 308
2024
Q3
$46.8K Hold
135
﹤0.01% 265
2024
Q2
$44.6K Sell
135
-24
-15% -$8.28K 0.01% 269
2024
Q1
$57.7K Sell
159
-5
-3% -$1.65K 0.01% 334
2023
Q4
$46.9K Hold
164
﹤0.01% 314
2023
Q3
$46.9K Buy
+164
New +$46.8K ﹤0.01% 314

Other funds holding CI

Salomon & Ludwin's CI Position: Q2 2026 in Review

Salomon & Ludwin reduced its Cigna (CI) stake by 15% in Q2 2026, selling an estimated $5.65K and leaving 115 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Salomon & Ludwin first reported a position in CI in Q3 2023 and has held it in 12 quarters since. The position peaked at $75K in Q3 2025. 1,692 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Salomon & Ludwin held 115 shares of Cigna worth $31.9K as of Q2 2026.
  • Salomon & Ludwin sold 20 Cigna shares in Q2 2026, an estimated $5.65K.
  • Cigna made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #807 holding.
  • Salomon & Ludwin first reported a position in Cigna in Q3 2023 and has held it in 12 quarters since.
  • Salomon & Ludwin's Cigna position peaked at $75K in Q3 2025.
  • 1,692 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.